Skip to content
value.today

Toltec Pharmaceuticals, LLC

Total raised
$4 M
1 round on record
Latest round
$4 M
Dec 2010
First round on record
Dec 2010
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Toltec Pharmaceuticals, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2010$4 MNo. 1$2 to $10 million

Toltec Pharmaceuticals, LLC: Raise no. 1, Dec 2010

Investors in this round

33 investors had bought by the notice of Jan 19, 2016: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$15,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Illinois

People named in the notice

  • Dawn Flynn · Executive Officer, Director · Member of the Issuer
  • Suzanne Gordon · Executive Officer, Director · Member of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Suzanne Gordon, Member. Source: SEC Form D and 2 amendments, newest notice filed Jan 19, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Toltec Pharmaceuticals, LLC chose not to state its revenue in its newest notice of a funding round (Jan 2016).

    SEC Form D · Jan 2016

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jan 2016

That is all the official record says: Toltec Pharmaceuticals, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Toltec Pharmaceuticals, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 33 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Toltec Pharmaceuticals, LLC
NameRoleNamed in
Dawn FlynnMember of the IssuerJan 2016
Suzanne GordonMember of the IssuerJan 2016
Dawn FlynnMember of the IssuerJan 2016
Suzanne GordonMember of the IssuerJan 2016